Ades, L., Guerci-Bresler, A., Cony-Makhoul, P., Legros, L., Sebert, M., Braun, T., . . . Fenaux, P. (2019). A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: A study by the Groupe Francophone des Myelodysplasies (GFM). Haematologica.
Chicago Style CitationAdes, Lionel, et al. "A Phase II Study of the Efficacy and Safety of an Intensified Schedule of Azacytidine in Intermediate-2 and High-risk Patients With Myelodysplastic Syndromes: A Study By the Groupe Francophone Des Myelodysplasies (GFM)." Haematologica 2019.
Cita MLAAdes, Lionel, et al. "A Phase II Study of the Efficacy and Safety of an Intensified Schedule of Azacytidine in Intermediate-2 and High-risk Patients With Myelodysplastic Syndromes: A Study By the Groupe Francophone Des Myelodysplasies (GFM)." Haematologica 2019.